256 Newsroom — Uganda's Digital News Infrastructure
Business

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class - STAT

Published by STAT By Adam Feuerstein · 14 August 2026 at 15:09
Share
FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class - STAT
Image · STAT

What the report says

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

256 Newsroom URA Lauds Manufacturers on Digital Tax Stamps Success - chimpreports.comChimpReports How Northern Uganda’s Artists Are Taking Local Sounds Beyond KampalaNile Post URA lauds Manufacturers on DTS successNile Post COSASE piles pressure on BoU over Shs140 billion Habba guaranteeThe Independent Uganda Housing Finance Bank deepens Hoima presence as Bunyoro economy expandsThe Independent Uganda 256 Newsroom Why URA must refund excess taxes - Daily MonitorDaily Monitor